NasdaqCM - Nasdaq Real Time Price USD

Baird Medical Investment Holdings Limited (BDMD)

5.60

+0.05

+(0.90%)

As of 1:57:21 PM EDT. Market Open.

Baird Medical Presents Advanced MWA Technology to UCLA Expert in China

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") recently hosted Dr. Gary G. Tse, a distinguished interventional radiologist from UCLA Health, for an immersive clinical visit in Guangzhou, China. The visit highlighted Baird Medical's cutting-edge microwave ablation (MWA) technology and its growing role in minimally invasive thyroid treatments.

PR Newswire 8 days ago

BDMD
+0.90%
BDMDW
Baird Medical Advances Global Expansion of Microwave Ablation Technology

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") recently announced a significant milestone in its international expansion. The U.S. Food and Drug Administration (FDA) has issued a Certificate to Foreign Government (CFG) to the Egyptian regulatory authorities, affirming the company's compliance with U.S. medical device standards and facilitating its market entry into Egypt. Simultaneously, Baird Medical has formally submitted regulatory registration applic

PR Newswire 13 days ago

BDMD
+0.90%
BDMDW
Baird Medical Showcases Advanced MWA Technology with UCSF Expert in Guangzhou and Shenzhen

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") proudly hosted Dr. Quan-Yang Duh, a world-renowned endocrine surgeon and Chief of Endocrine Surgery at the University of California, San Francisco (UCSF), for an in-depth clinical observation visit in Guangzhou and Shenzhen, China. During his visit, Dr. Duh closely examined the real-world application of Baird Medical's advanced microwave ablation (MWA) technology.

PR Newswire 20 days ago

BDMD
+0.90%
BDMDW
Baird Medical's MWA Technology Successfully Applied in Endocrine Procedures

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") proudly announces the successful utilization of its advanced microwave ablation (MWA) technology in two recent endocrine procedures . These procedures were performed by Dr. Saka Kazeem, MD, a distinguished endocrinologist with over 30 years of clinical experience.

PR Newswire 22 days ago

BDMD
+0.90%
BDMDW
Baird Medical Wins "Most Valuable Investment Award" for AI Tumor Ablation Surgical Robot

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") has been honored with the "Most Valuable Investment Award" at the 10th China Medical Industry Innovation Competition, recognizing its groundbreaking AI Tumor Ablation Surgical Robot.

PR Newswire 29 days ago

BDMD
+0.90%
BDMDW
Baird Medical's AI Tumor Ablation Surgical Robot Wins "Most Valuable Investment Award," Pioneering AI and Robotics Integration in Healthcare

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") has been honored with the "Most Valuable Investment Award" at the 10th China Medical Industry Innovation Competition with its revolutionary in-development product, the "AI Tumor Ablation Surgical Robot." This prestigious recognition marks a significant milestone in the advancement of AI and robotics integration that Baird Medical is developing in the medical field.

PR Newswire last month

BDMD
+0.90%
BDMDW
Baird Medical Secures Indonesian Regulatory Approval for Microwave Ablation Technology

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical instruments, and a global leader in microwave ablation (MWA) technology, has received regulatory approval from the Indonesian Ministry of Health (Kementerian Kesehatan Republik Indonesia). This approval includes the Great Wall Microwave Therapeutic Instrument and the Great Wall Disposable Micr

PR Newswire last month

BDMD
+0.90%
BDMDW
Baird Medical Showcases Cutting-Edge MWA Innovations at NASOIE 2025

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical instruments, and a global leader in microwave ablation (MWA) technology, made a lasting impact at the 2025 North American Society of Interventional Endocrinologists (NASOIE) Annual Meeting in Lehi, Utah.

PR Newswire last month

BDMD
+0.90%
BDMDW
Baird Medical Expands Global MWA Training with Expert-Led Program in Guangzhou

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical instruments, and a leading innovator in microwave ablation (MWA) technology, continues to strengthen international medical collaboration. The Company recently hosted a delegation of distinguished Bangladeshi physicians at its Guangzhou headquarters for an expert-led MWA training program, furth

PR Newswire last month

BDMD
+0.90%
BDMDW
With 51% ownership, Baird Medical Investment Holdings Limited (NASDAQ:BDMD) insiders have a lot at stake

Key Insights Baird Medical Investment Holdings' significant insider ownership suggests inherent interests in company's...

Simply Wall St. 2 months ago

BDMD
+0.90%
BDMDW
Baird Medical Advances MWA Training with Expert-Led Course at Columbia Thyroid Center

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in microwave ablation (MWA) technology, remains committed to advancing physician education and recently supported Dr. Hosai Todd-Hesham's participation in a specialized MWA training program at the Columbia Thyroid Center in New York City.

PR Newswire 2 months ago

BDMD
+0.90%
BDMDW
Baird Medical Showcases Groundbreaking MWA Innovations at NASIT 2025

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in microwave ablation (MWA) technology, made a significant impact at the 2025 North American Society for Interventional Thyroidology (NASIT) conference. Building on the success of its NASIT 2024 participation, Baird Medical returned to this premier event to engage with industry leaders and showcase the clinical advantages of its cutting-edge MWA technology for thyroid treatment.

PR Newswire 2 months ago

BDMD
+0.90%
BDMDW
Baird Medical Shines at 2025 Microcap Conference: Driving Growth Through Technological Innovation and Strategic Collaborations

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in microwave ablation (MWA) technology, today announced its successful participation in the 2025 Microcap Conference, held at the Borgata Hotel in Atlantic City, New Jersey. The Company showcased its innovative solutions and engaged in high-level discussions with investors and industry leaders during the 3-day event.

PR Newswire 2 months ago

BDMD
+0.90%
BDMDW
Baird Medical Celebrates 2024 Breakthroughs and Accolades, Forging a New Era in Minimally Invasive MWA Technology

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, reflects on a landmark year of innovation and achievement. Despite global market uncertainties, the Company remained at the forefront of medical technology, driving advancements in MWA solutions and expanding its presence in the global healthcare sector.

PR Newswire 2 months ago

BDMD
+0.90%
BDMDW
Baird Medical to Participate in NASIT 2025 Conference

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 2025 North American Society for Interventional Thyroidology (NASIT) Conference, taking place January 31 – February 1, 2025, in Washington, D.C.

PR Newswire 2 months ago

BDMD
+0.90%
BDMDW
Baird Medical to Attend Microcap Conference at Borgata Hotel

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in microwave ablation technology (MWA), announced today that it will participate in the highly anticipated Microcap Conference, set to take place at the Borgata Hotel in Atlantic City, New Jersey, from January 28 to January 30, 2025.

PR Newswire 2 months ago

BDMD
+0.90%
BDMDW
Baird Medical Expands into San Francisco, Advancing U.S. Market Growth

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, is expanding its presence into San Francisco, marking an important step in its U.S. growth strategy. This expansion follows the recent J.P. Morgan Health Conference in San Francisco, highlighting the company's early success in executing its strategic vision for medical innovation.

PR Newswire 2 months ago

BDMD
+0.90%
BDMDW
Dr. Emad Kandil Achieves Milestone of 100 Microwave Ablation Cases in Thyroid Care

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, proudly announces that Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery at Tulane University School of Medicine, has reached a remarkable milestone of successfully completing 100 MWA procedures for thyroid nodules. This achievement underscores both the growing adoption of MWA and the transformative potential of the technology in

PR Newswire 2 months ago

BDMD
+0.90%
BDMDW
Baird Medical Engages with Healthcare Leaders Amid 2025 J.P. Morgan Healthcare Conference

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, was present in San Francisco amid the 2025 J.P. Morgan Healthcare Conference, one of the most prominent healthcare investment gatherings globally.

PR Newswire 3 months ago

BDMD
+0.90%
BDMDW
Baird-Sponsored Microwave Ablation Training Advances Thyroid Treatment

Baird Medical (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology, recently sponsored another advanced MWA training session in New Orleans. This program offered physicians practical experience with a state-of-the-art treatment designed to deliver quicker recovery and effective management of thyroid nodules.

PR Newswire 3 months ago

BDMD
+0.90%
BDMDW

Performance Overview

Return	BDMD	S&P 500 (^GSPC)
YTD	-26.32%	-10.40%
1-Year	-49.09%	+5.18%
3-Year	-43.89%	+23.37%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Baird Medical Investment Holdings Limited (BDMD)

Baird Medical Presents Advanced MWA Technology to UCLA Expert in China

Baird Medical Advances Global Expansion of Microwave Ablation Technology

Baird Medical Showcases Advanced MWA Technology with UCSF Expert in Guangzhou and Shenzhen

Baird Medical's MWA Technology Successfully Applied in Endocrine Procedures

Baird Medical Wins "Most Valuable Investment Award" for AI Tumor Ablation Surgical Robot

Baird Medical's AI Tumor Ablation Surgical Robot Wins "Most Valuable Investment Award," Pioneering AI and Robotics Integration in Healthcare

Baird Medical Secures Indonesian Regulatory Approval for Microwave Ablation Technology

Baird Medical Showcases Cutting-Edge MWA Innovations at NASOIE 2025

Baird Medical Expands Global MWA Training with Expert-Led Program in Guangzhou

With 51% ownership, Baird Medical Investment Holdings Limited (NASDAQ:BDMD) insiders have a lot at stake

Baird Medical Advances MWA Training with Expert-Led Course at Columbia Thyroid Center

Baird Medical Showcases Groundbreaking MWA Innovations at NASIT 2025

Baird Medical Shines at 2025 Microcap Conference: Driving Growth Through Technological Innovation and Strategic Collaborations

Baird Medical Celebrates 2024 Breakthroughs and Accolades, Forging a New Era in Minimally Invasive MWA Technology

Baird Medical to Participate in NASIT 2025 Conference

Baird Medical to Attend Microcap Conference at Borgata Hotel

Baird Medical Expands into San Francisco, Advancing U.S. Market Growth

Dr. Emad Kandil Achieves Milestone of 100 Microwave Ablation Cases in Thyroid Care

Baird Medical Engages with Healthcare Leaders Amid 2025 J.P. Morgan Healthcare Conference

Baird-Sponsored Microwave Ablation Training Advances Thyroid Treatment

Performance Overview